An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma
| dc.contributor.author | Spies, Elmar | |
| dc.contributor.author | Reichardt, Wilfried | deu |
| dc.contributor.author | Alvarez Salinas, Gerardo Omar | |
| dc.contributor.author | Groettrup, Marcus | |
| dc.contributor.author | Öhlschläger, Peter | |
| dc.date.accessioned | 2012-04-04T13:38:31Z | deu |
| dc.date.available | 2012-04-04T13:38:31Z | deu |
| dc.date.issued | 2012-03 | |
| dc.description.abstract | Prostate cancer (PCa) is the most commonly diagnosed type of cancer in men in western industrialized countries. As a public health burden, the need for the invention of new cost-saving PCa immunotherapies is apparent. In this study, we present a DNA vaccine encoding for the prostate-specific antigen prostatic acid phosphatase (PAP) linked to the J-domain and the SV40 enhancer sequence. The PAP DNA vaccine induced a strong PAP-specific cellular immune response after electroporation (EP)-based delivery in C57BL/6 mice. Splenocytes from mice immunized with PAP recognized the naturally processed PAP epitopes, indicating that vaccination with the PAP-J gene broke its self-tolerance against PAP. Remarkably, DNA vaccination with PAP-J inhibited tumor growth in the Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) mouse model that closely resembled human PCa. Therefore, this study highlights a novel cancer immunotherapy approach with the potential to control PCa in clinical settings. | eng |
| dc.description.version | published | |
| dc.identifier.citation | Publ. in: Molecular Therapy ; 20 (2012), 3. S. 555–564 | deu |
| dc.identifier.doi | 10.1038/mt.2011.241 | deu |
| dc.identifier.pmid | 22086231 | |
| dc.identifier.ppn | 499792637 | |
| dc.identifier.uri | http://kops.uni-konstanz.de/handle/123456789/18035 | |
| dc.language.iso | eng | deu |
| dc.legacy.dateIssued | 2012-04-04 | deu |
| dc.rights | terms-of-use | deu |
| dc.rights.uri | https://rightsstatements.org/page/InC/1.0/ | deu |
| dc.subject.ddc | 570 | deu |
| dc.title | An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma | eng |
| dc.type | JOURNAL_ARTICLE | deu |
| dspace.entity.type | Publication | |
| kops.citation.bibtex | @article{Spies2012-03artif-18035,
year={2012},
doi={10.1038/mt.2011.241},
title={An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma},
number={3},
volume={20},
issn={1525-0016},
journal={Molecular Therapy},
pages={555--564},
author={Spies, Elmar and Reichardt, Wilfried and Alvarez Salinas, Gerardo Omar and Gröttrup, Marcus and Öhlschläger, Peter}
} | |
| kops.citation.iso690 | SPIES, Elmar, Wilfried REICHARDT, Gerardo Omar ALVAREZ SALINAS, Marcus GRÖTTRUP, Peter ÖHLSCHLÄGER, 2012. An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma. In: Molecular Therapy. 2012, 20(3), pp. 555-564. ISSN 1525-0016. eISSN 1525-0024. Available under: doi: 10.1038/mt.2011.241 | deu |
| kops.citation.iso690 | SPIES, Elmar, Wilfried REICHARDT, Gerardo Omar ALVAREZ SALINAS, Marcus GRÖTTRUP, Peter ÖHLSCHLÄGER, 2012. An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma. In: Molecular Therapy. 2012, 20(3), pp. 555-564. ISSN 1525-0016. eISSN 1525-0024. Available under: doi: 10.1038/mt.2011.241 | eng |
| kops.citation.rdf | <rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/18035">
<dc:creator>Spies, Elmar</dc:creator>
<dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/18035/2/Spies_180353.pdf"/>
<dc:contributor>Öhlschläger, Peter</dc:contributor>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-04-04T13:38:31Z</dcterms:available>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dcterms:abstract xml:lang="eng">Prostate cancer (PCa) is the most commonly diagnosed type of cancer in men in western industrialized countries. As a public health burden, the need for the invention of new cost-saving PCa immunotherapies is apparent. In this study, we present a DNA vaccine encoding for the prostate-specific antigen prostatic acid phosphatase (PAP) linked to the J-domain and the SV40 enhancer sequence. The PAP DNA vaccine induced a strong PAP-specific cellular immune response after electroporation (EP)-based delivery in C57BL/6 mice. Splenocytes from mice immunized with PAP recognized the naturally processed PAP epitopes, indicating that vaccination with the PAP-J gene broke its self-tolerance against PAP. Remarkably, DNA vaccination with PAP-J inhibited tumor growth in the Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) mouse model that closely resembled human PCa. Therefore, this study highlights a novel cancer immunotherapy approach with the potential to control PCa in clinical settings.</dcterms:abstract>
<dcterms:issued>2012-03</dcterms:issued>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dcterms:bibliographicCitation>Publ. in: Molecular Therapy ; 20 (2012), 3. S. 555–564</dcterms:bibliographicCitation>
<dc:contributor>Spies, Elmar</dc:contributor>
<bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/18035"/>
<dcterms:title>An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinoma</dcterms:title>
<dc:creator>Alvarez Salinas, Gerardo Omar</dc:creator>
<dc:creator>Reichardt, Wilfried</dc:creator>
<dc:contributor>Alvarez Salinas, Gerardo Omar</dc:contributor>
<dc:language>eng</dc:language>
<dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/18035/2/Spies_180353.pdf"/>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:contributor>Gröttrup, Marcus</dc:contributor>
<dc:creator>Gröttrup, Marcus</dc:creator>
<dc:creator>Öhlschläger, Peter</dc:creator>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-04-04T13:38:31Z</dc:date>
<dc:rights>terms-of-use</dc:rights>
<dc:contributor>Reichardt, Wilfried</dc:contributor>
<dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
</rdf:Description>
</rdf:RDF> | |
| kops.description.openAccess | openaccessgreen | |
| kops.flag.knbibliography | true | |
| kops.identifier.nbn | urn:nbn:de:bsz:352-180353 | deu |
| kops.sourcefield | Molecular Therapy. 2012, <b>20</b>(3), pp. 555-564. ISSN 1525-0016. eISSN 1525-0024. Available under: doi: 10.1038/mt.2011.241 | deu |
| kops.sourcefield.plain | Molecular Therapy. 2012, 20(3), pp. 555-564. ISSN 1525-0016. eISSN 1525-0024. Available under: doi: 10.1038/mt.2011.241 | deu |
| kops.sourcefield.plain | Molecular Therapy. 2012, 20(3), pp. 555-564. ISSN 1525-0016. eISSN 1525-0024. Available under: doi: 10.1038/mt.2011.241 | eng |
| kops.submitter.email | brigitte.schanze@uni-konstanz.de | deu |
| relation.isAuthorOfPublication | 59fcbc08-2f8a-47fb-9502-e1b1862c4bb1 | |
| relation.isAuthorOfPublication | 24e38d42-c203-4d82-afc5-b03a659ca1d3 | |
| relation.isAuthorOfPublication | 9a4b66b7-717a-4354-b1e2-15a4385ddaa5 | |
| relation.isAuthorOfPublication | ddaeb5ee-793e-4f79-a1d1-b598724bc771 | |
| relation.isAuthorOfPublication.latestForDiscovery | 59fcbc08-2f8a-47fb-9502-e1b1862c4bb1 | |
| source.bibliographicInfo.fromPage | 555 | |
| source.bibliographicInfo.issue | 3 | |
| source.bibliographicInfo.toPage | 564 | |
| source.bibliographicInfo.volume | 20 | |
| source.identifier.eissn | 1525-0024 | |
| source.identifier.issn | 1525-0016 | |
| source.periodicalTitle | Molecular Therapy |
Dateien
Originalbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- Spies_180353.pdf
- Größe:
- 258.55 KB
- Format:
- Adobe Portable Document Format
- Beschreibung:
Lizenzbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- license.txt
- Größe:
- 1.92 KB
- Format:
- Plain Text
- Beschreibung:

